Literature DB >> 139214

Target organ damage in black hypertensives.

G Entwisle, A Y Apostolides, J R Hebel, M M Henderson.   

Abstract

A representative sample of black hypertensives has been appraised to determine candidacy for hypertension treatment. A total of 1759 black residents were successfully screened at home. Forty-one percent of the males and 33% of the females had diastolic blood pressures of 95 mm Hg or greater. They were invited for secondary screening along with those hypertensives controlled on therapy. Clinical and laboratory evidence of cardiovascular disease was common among examined patients who were studied to determine their eligibility for therapy based on criteria of elevated blood pressure (greater than 104 mm Hg) at two visits, or evidence of end organ damage at lowere blood pressure levels. Of patients previously aware of their hypertension but not on therapy, 88% of the males and 67% of the females were considered candidates for therapy. Of patients not previously aware of their elevated blood pressure, 72% of the males and 67% of the females were considered candidates.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 139214     DOI: 10.1161/01.cir.55.5.792

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Black/white differences in response to antihypertensive therapy.

Authors:  B J Materson
Journal:  J Natl Med Assoc       Date:  1985-05       Impact factor: 1.798

2.  Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

Authors:  Jennifer J Gassman; Tom Greene; Jackson T Wright; Lawrence Agodoa; George Bakris; Gerald J Beck; Janice Douglas; Ken Jamerson; Julia Lewis; Michael Kutner; Otelio S Randall; Shin-Ru Wang
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

3.  Cerebrovascular disease in blacks.

Authors:  L R Caplan; E S Cooper
Journal:  J Natl Med Assoc       Date:  1987-01       Impact factor: 1.798

Review 4.  Cardiovascular pathophysiology of essential hypertension: a clue to therapy.

Authors:  F H Messerli; H O Ventura
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 5.  Management of essential hypertension in the black patient: profiling as the initial approach to treatment.

Authors:  F H Messerli
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.